Perspectives on the relationship of adrenal steroids to rheumatoid arthritis

被引:14
|
作者
Masi, AT [1 ]
Chatterton, RT
Aldag, JC
Malamet, RL
机构
[1] Univ Illinois, Coll Med, Dept Med, Peoria, IL 61656 USA
[2] Northwestern Univ, Sch Med, Dept Obstet & Gynecol, Chicago, IL USA
[3] Osteoporosis & Clin Trials Ctr, Hagerstown, MD USA
来源
NEUROENDOCRINE IMMUNE BASIS OF THE RHEUMATIC DISEASES II, PROCEEDINGS | 2002年 / 966卷
关键词
adrenal steroids; rheumatoid arthritis; cortisol; DHEAS;
D O I
10.1142/9789812777492_0001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
An expanded model of RA is presented that incorporates cumulative multifactorial processes operating over a prolonged physiological phase prior to initial clinical manifestations. During this phase, progressive imbalances in the homeostasis of core neuroendocrine, immunological, and microvascular systems are believed to occur. Normal adrenal function plays an essential role in helping to maintain homeostasis of core systems in health. In RA, chronic adrenal hypocompetence is suspected to occur in a minority subset of females who have younger clinical onset and males who have associated low serum testosterone levels. Chronic, relative glucocorticoid insufficiency is believed to contribute to development of inflammatory manifestations in RA patients. Androgenic deficiencies, particularly of gonadal origin in males, may also contribute to RA, particularly its decreased anabolic features. Precise influences of hypocompetent adrenal steroid function on long-term modeling of the immunological compartment and control of microvascular activation processes are not well understood. These complex mechanisms need to be elucidated for better understanding of the physiopathogenesis of RA. Nevertheless, at a clinical level, sufficient data are currently available to endorse further controlled studies of early clinical onset patients and prospective investigations to determine more definitively the roles of adrenal (and gonadal) steroids in subsets of RA patients and unaffected susceptible persons in the population.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 50 条
  • [1] Glucocorticoid effects on adrenal steroids and cytokine responsiveness in polymyalgia rheumatica and elderly onset rheumatoid arthritis
    Sulli, Alberto
    Montecucco, Carlo Maurizio
    Caporali, Roberto
    Cavagna, Lorenzo
    Montagna, Paola
    Capellino, Silvia
    Fazzuoli, Laura
    Seriolo, Bruno
    Alessandro, Calvia
    Secchi, Maria Elena
    Cutolo, Maurizio
    BASIC AND CLINICAL ASPECTS OF NEUROENDOCRINE IMMUNOLOGY IN RHEUMATIC DISEASES, 2006, 1069 : 307 - 314
  • [2] Update on the use of steroids in rheumatoid arthritis
    Garcia-Magallon, Blanca
    Silva-Fernandez, Lucia
    Luis Andreu-Sanchez, Jose
    REUMATOLOGIA CLINICA, 2013, 9 (05): : 297 - 302
  • [3] STEROIDS IN RHEUMATOID ARTHRITIS - TIME FOR REPREAVAL
    Prabu, N.
    Petciappan, V.
    Anand, G.
    Kumar, A.
    Ram, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1420 - 1421
  • [4] Hypothalamic-Pituitary-Adrenal Axis in Rheumatoid Arthritis
    Imrich, Richard
    Rovensky, Jozef
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2010, 36 (04) : 721 - +
  • [5] The role of the hypothalamic-pituitary-adrenal axis in rheumatoid arthritis
    Eijsbouts, AMM
    Murphy, EP
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 1999, 13 (04): : 599 - 613
  • [6] Determinants of Adrenal Androgen Hypofunction in Premenopausal Females With Rheumatoid Arthritis
    Imrich, R.
    Vlcek, M.
    Kerlik, J.
    Vogeser, M.
    Kirchhoff, F.
    Penesova, A.
    Radikova, Z.
    Lukac, J.
    Rovensky, J.
    PHYSIOLOGICAL RESEARCH, 2014, 63 (03) : 321 - 329
  • [7] Use of Glucocorticosteroids in Rheumatoid Arthritis. How and When Should Steroids Be Used in Rheumatoid Arthritis?
    Silva Fernandez, Lucia
    Fernandez Castro, Monica
    Andreu Sanchez, Jose Luis
    REUMATOLOGIA CLINICA, 2007, 3 (06): : 262 - 269
  • [8] Hypothalamic-pituitary-adrenal axis activity in patients with rheumatoid arthritis
    Eijsbouts, AMM
    van den Hoogen, FHJ
    Laan, RFJM
    Hermus, ARMM
    Sweep, CGJ
    van de Putte, LBA
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (05) : 658 - 664
  • [9] Juvenile rheumatoid arthritis: Therapeutic perspectives
    Chikanza I.C.
    Pediatric Drugs, 2002, 4 (5) : 335 - 348
  • [10] Cellular and molecular perspectives in rheumatoid arthritis
    Douglas J. Veale
    Carl Orr
    Ursula Fearon
    Seminars in Immunopathology, 2017, 39 : 343 - 354